Research lines

• Prognostic factors in patients with macular edema associated with non-infectious uveitis

  Assessment of the clinical, biological and imaging factors involved in the pathogenesis of uveitic macular edema and its response to treatment.

• New biologic therapies for the treatment of non-infectious uveitis

  Assessment of the efficacy and safety of new biologic therapies including anti-TNF-alpha, anti-IL-1beta, and anti-IL-6 receptor monoclonal antibodies for treating patients with non-infectious uveitis.

• Genetic polymorphisms predisposing to uveitis

  Multicentric study that investigates genetic polymorphisms as potential risk factors for developing uveitis and its complications.

• Tuberculosis-related uveitis

  Development of epidemiological, clinical and experimental studies.

• Macular pathology in diabetic patients

  Development of clinical and experimental studies to investigate the pathogenesis of diabetic macular edema, as well as its response to different therapeutic approaches.

• Molecular basis of age-related macular degeneration (AMD)

  Study of the contribution of chronic inflammation and in particular, C-reactive protein and complement Factor H to the progression of AMD.

• Glaucoma

  Molecular genetics of glaucoma, proteomics of glaucoma secondary to uveitis, and applications of the structural analysis by OCT in glaucoma.